Key result
Tachycardia in Takotsubo syndrome is linked to ~318% higher MACCE risk over 3 years.
Why the study?
Clinical features and outcomes of Chinese patients with Takotsubo syndrome were not previously characterized in a national registry.
Observational (n=112)
In Chinese patients with Takotsubo syndrome, tachycardia is a strong predictor of adverse events, whereas beta-blocker therapy at discharge may be associated with improved long-term outcomes.
Answers are grounded in this paper and cite their sources.
Tachycardia signals higher MACE risk in Takotsubo syndrome; hypothesis-generating and requires prospective validation before guiding care.
OBJECTIVE: To investigate clinical features and outcomes of Chinese patients with Takotsubo syndrome (TTS). METHODS: We established the first Chinese Registry of Takotsubo Syndrome (ChiTTS Registry) and analyzed demographic, clinical, therapeutical, and outcome data to characterize clinical and outcome features of Chinese TTS patients. RESULTS: In 112 enrolled patients in the ChiTTS registry from 02/01/2016 to 12/28/2021, the mean age was 59.4 ± 18.7 years old, and 27.7% were men. A total of 41.1% patients experienced respiratory and circulatory complications during hospitalization, and 17.3% patients developed cardiogenic shock. Physical triggers, dyspnea, tachycardia, and younger age (< 70 years old) predicted in-hospital complications. The MACCE rate during follow up was 13.9% per patient per year and the rate of all-cause death was 12.8% per patient per year. TTS patients with in-hospital complications developed more long-term MACCE (24.6% vs. 6.6% per patient-year, P < 0.001) and higher all-cause mortality (21.9% vs. 6.6% per patient-year, P = 0.001) than those without. The Kaplan-Meier survival analysis showed that more MACCE occurred in TTS patients with tachycardia during 3-year follow-up (HR 4.18; 95% CI 1.80-9.74; log-rank test P < 0.001). Among all medications at discharge, only beta-blocker was associated with reduced long-term MACCE (HR: 0.35; 95% CI: 0.12-0.996; P = 0.049). CONCLUSION: We investigated clinical and outcome features of patients in the first Chinese TTS Registry. Tachycardiac TTS patients developed more inpatient and long-term adverse cardiovascular events.
No takes yet. Share an insight, caveat, or question.
Chong et al. (2023) conducted an observational in Takotsubo syndrome (n=112). Tachycardia vs. Absence of tachycardia was evaluated on Major adverse cardiovascular and cerebrovascular events (MACCE) (HR 4.18, 95% CI 1.80-9.74, p=<0.001). Tachycardia in patients with Takotsubo syndrome was associated with a significantly higher risk of major adverse cardiovascular events over 3 years (HR 4.18; 95% CI 1.80-9.74; P<0.001).
Synapse has enriched 10 related papers. Consider them for comparative context: